Somatuline LA 30mg, powder and solvent for prolonged-release suspension for injection

Licence status
Withdrawn: 01/03/2022
Active substances
Lanreotide
Dosage Form
Powder and solvent for prolonged-release suspension for injection
Licence number
PA0869/004/001
Licence holder
Ipsen Pharmaceuticals Limited

Product documents

Licence information

ATC code
H01CB Somatostatin and analogues, H01CB03 lanreotide
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Marketing availability
Marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
15/06/1998